GC Cell said Tuesday it had discussed the potential introduction of its immune cell therapy Immuncell-LC in Türkiye and ...
Nearly nine in 10 Korean adults believe weight-loss drugs, including prescription appetite suppressants, are widely misused ...
MADRID, Spain -- By Hong Sook / Korea Biomedical Review correspondent -- Samsung Bioepis’ Keytruda biosimilar candidate SB27 ...
Korea’s biohealth exports rose 19.4 percent to a record $24.75 billion in the first nine months of 2026, led by a 31 percent ...
Electrophysiologists shared clinical data and experience with Medtronic’s PulseSelect pulsed field ablation (PFA) system and ...
Dong-A ST said Tuesday it presented preclinical findings supporting the potential development of a topical formulation of ...
Siemens Healthineers Korea said Tuesday it is promoting its Enhanced Liver Fibrosis (ELF) blood test to Korean laboratory ...
Samyang Biopharm and CrossPoint Therapeutics signed a memorandum of understanding last Friday to develop next-generation gene ...
Daewon Pharmaceutical said its oral semaglutide candidate DW5324 showed up to 3.14 times higher drug exposure than Novo’s ...
News of a new cancer treatment recently made headlines on major online portals.The treatment, which drew attention from ...
Celltrion said Tuesday its preliminary consolidated operating profit for the third quarter rose 74.3 percent from a year ...
LigaChem Biosciences said Monday its claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC) LCB02A suppressed tumor growth for about two months after a single dose in animal models of gastric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results